Medicofarma Biotech S.A. Stock: price and insider trades · Poland
Medicofarma Biotech S.A.: what insiders have been doing
This page follows insider dealings at Medicofarma Biotech S.A. as filed with KNF. In the past year (22 October 2025 to 22 October 2026), 4 filings came from 3 insiders.
The flow runs one way only: 2 sales worth €2.7M, from 2 insiders, and no purchase. Vitama S.A. filed the largest sale, €2.7M, on 27 January 2026.
Filings reach the KNF feed a median of 3 days after the trade. The legal deadline for notifying a trade is three business days (MAR article 19). Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
Compared with its exchange (553 companies, median 3 filings), a count of 4 filings is above the norm. Our records for Medicofarma Biotech S.A. go back to 2026, with no purchases and 2 sales on the open market in total.
Every figure here comes from the filings published by KNF and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
- 194,876 shares@ PLN 0.4752100.0% of flowShareWSEKNF:node/732993
- ●Executives0KNF
- ●Executives0KNF
- 46,268,936 shares@ PLN 0.2464100.0% of flowShareWSEKNF:node/713971
4 of 4 declarations
About Medicofarma Biotech S.A.
Medicofarma Biotech S.A. is a biopharmaceutical company focused on developing innovative health solutions. It is listed on the XWAR market.